Resource:Beta Cell Biology Consortium
Categories related to Resource:Beta Cell Biology Consortium
Parts of Resource:Beta Cell Biology Consortium
Curation status: Uncurated
This resource will be curated within 7 days.
For Resource Owners:
After the resource is curated, you may create a sitemap, which will help keep your registry description up-to-date and inform search engines about your resource.
Note: For a new resource, the website's URL must first be verified by a NIF curator before you may proceed.
Learn more about what NIF can do for your resource.
Proudly proclaim your inclusion in NIF by displaying the "Registered with NIF" button on your site. Please login to create the sitemap. (top right)
This page uses this default form:Resource
*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.
|Address||The Beta Cell Biology Consortium +, Vanderbilt Center for Stem Cell Biology +, 2213 +, Garland Avenue +, 9465 MRB IV +, Nashville +, and TN 37232-0494 Telephone: 615.936.8327 Fax: 615.322.6645 +|
|Availability||Public +, and The community can contribute to this resource +|
|Category||Type 2 diabetes +, and Type 1 diabetes +|
|Comment||Sample type: Cell line, Embryonic stem cel … Sample type: Cell line, Embryonic stem cell line
Access: open; Copyrights - http://www.mgtaylor.com/ |
Reuse: closed; Copyrights - http://www.betacell.org/content/disclaimerterms/#terms
Start date: 2002
Deposit: restricted: registration
(info provided by re3data.org) tion
(info provided by re3data.org)
|Definition||The mission of the Beta Cell Biology Conso … The mission of the Beta Cell Biology Consortium is to facilitate interdisciplinary collaborations to advance the understanding of pancreatic islet development and function, with the goal of developing innovative therapies to correct the loss of beta cell mass in diabetes, including cell reprogramming, regeneration and replacement. programming, regeneration and replacement.|
|EditorialNote||Each of these databases should probably have their own entry, as per NIF resource curation guidelines.|
|Grant||Category:DK-01-014 +, Category:DK-01-17 +, Category:DK-01-18 +, and Category:DK-09-011 +|
|Has default formThis property is a special property in this wiki.||Resource +|
|Has role||Database +, Community building portal +, Data repository +, Biospecimen repository +, Cell repository +, Organism supplier +, Experimental protocol +, and Antibody supplier +|
|Is part of||Vanderbilt University; Tennessee; USA +|
|Keywords||Pancreatic islet +, Diabetes +, Mouse +, Beta cell +, Pancreas +, Pancreatic development +, Embryonic stem cell +, Cell line +, Genomics +, Antibody +, Adenovirus +, Functional genomics +, Mouse Embryonic stem cell line +, Mouse strain +, Protocol +, Embryonic stem cell line +, Data sharing +, Data set +, Gene expression +, and Gene +|
|Label||Resource:Beta Cell Biology Consortium +|
|Listedby||Resource:One Mind Biospecimen Bank Listing +, and US Biobank +|
|ModifiedDate||30 September 2014 +|
|Page has default formThis property is a special property in this wiki.||Resource +|
|RelatedTo||Resource:One Mind Biospecimen Bank Listing +, US Biobank +, Resource:NIF Data Federation +, Resource:DKnet +, and Resource:re3data.org +|
|Related application||Research +|
|Related disease||Pancreatic islet development and function +, Type 2 diabetes +, and Type 1 diabetes +|
|Species||Mouse +, and Non-human animal +|
|Supporting Agency||NIDDK +|